These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 24419643

  • 1. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z, Parton M.
    BMJ Case Rep; 2014 Jan 13; 2014():. PubMed ID: 24419643
    [Abstract] [Full Text] [Related]

  • 2. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
    Tohid H.
    Neurosciences (Riyadh); 2016 Jul 13; 21(3):215-22. PubMed ID: 27356651
    [Abstract] [Full Text] [Related]

  • 3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C, Hieronimus S, Ferrari P, Thomas P, Lebrun C.
    Diabetes Metab; 2008 Sep 13; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
    Pedroso JL, Braga-Neto P, Dutra LA, Barsottini OG.
    Arq Neuropsiquiatr; 2011 Dec 13; 69(6):993. PubMed ID: 22297896
    [No Abstract] [Full Text] [Related]

  • 7. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
    Jazebi N, Rodrigo S, Gogia B, Shawagfeh A.
    J Neuroimmunol; 2019 Jul 15; 332():135-137. PubMed ID: 31015081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
    Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A.
    Intern Med; 2001 Sep 15; 40(9):968-71. PubMed ID: 11579968
    [Abstract] [Full Text] [Related]

  • 10. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F.
    Brain; 2008 Oct 15; 131(Pt 10):2553-63. PubMed ID: 18687732
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
    Aguiar TS, Fragoso A, Albuquerque CR, Teixeira PF, Souza MV, Zajdenverg L, Alves-Leon SV, Rodacki M, Lima MA.
    Arq Neuropsiquiatr; 2017 Mar 15; 75(3):142-146. PubMed ID: 28355320
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
    Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saito H, Otsuka T, Mitoma H, Koizumi K.
    Intern Med; 2009 Mar 15; 48(10):783-90. PubMed ID: 19443972
    [Abstract] [Full Text] [Related]

  • 14. Neurological Syndromes Associated with Anti-GAD Antibodies.
    Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, Psimaras D, Alentorn A.
    Int J Mol Sci; 2020 May 24; 21(10):. PubMed ID: 32456344
    [Abstract] [Full Text] [Related]

  • 15. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F.
    Arch Neurol; 2001 Feb 24; 58(2):225-30. PubMed ID: 11176960
    [Abstract] [Full Text] [Related]

  • 16. Plasmapheresis and IVIG for Treatment of Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia: A Case Report.
    Adibi A, Rastegar-Kashkouli A, Yousefi P, Adibi I, Ahmadi E, Naghavi S.
    Cerebellum; 2024 Oct 24; 23(5):2208-2213. PubMed ID: 38874737
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B, Cabre P, Bonnan M, Olindo S, Smadja D.
    Rev Med Interne; 2006 Aug 24; 27(8):616-9. PubMed ID: 16797794
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F.
    Neurology; 1997 Oct 24; 49(4):1026-30. PubMed ID: 9339684
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC, Pedroso JL, Alquéres RA, Dutra LA, Barsottini OG.
    J Neurol Sci; 2015 Dec 15; 359(1-2):21-3. PubMed ID: 26671081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.